Retraction – Horizon scanning for novel therapeutics for the treatment of prostate cancer

Author：

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.10, 2011-10, pp. : 1591-1591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Castration-resistant Prostate Cancer: Novel Therapeutics Pre- or Post- Taxane Administration

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-05 ,pp. : 444-459

Bentham Science Publishers

Access to resources Recommend Favorite

Target Acquired: Progress and Promise of Targeted Therapeutics in the Treatment of Prostate Cancer

Current Cancer Drug Targets, Vol. 15, Iss. 5, 2015-01 ,pp. : 394-405

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutics for the treatment of asthma

By Chantry D.

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 321-328

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Thematic Issue: Lutetium-177 Labeled Therapeutics: 177Lu-PSMA is Set to Redefine Prostate Cancer Treatment)

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 6-7

Bentham Science Publishers

Access to resources Recommend Favorite

Measles virotherapy in prostate cancer treatment: a novel antitumor approach

By Msaouel Pavlos Galanis Evanthia

Future Virology, Vol. 4, Iss. 3, 2009-05 ,pp. : 203-207

Future Medicine

Access to resources Recommend Favorite